This peptide supports a wide range of health goals, including improved physical performance, sleep quality, energy levels, weight loss and management, cognitive function, and more
[18] [19] Phase 2 trial data published in the New England Journal of Medicine (2023) demonstrated substantial weight loss with retatrutide, but also confirmed that gastrointestinal side effects including diarrhoea were among the most commonly reported adverse events
Women of childbearing potential should discuss contraception with their clinician before entering a trial of any weight-management medicine
Instead, angle the needle so the stream of BAC water runs gently down the inside wall of the glass vial
however, given the trial design, a relationship between the lower native GLP-1 levels in the trial population and the higher %WL could not be inferred
Company: MedisourceRx Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: December 12, 2025